Toralf Zarnt
15Patents
2h-index
20Co-inventors
50Inventor score
Filing activity: Oct 23, 2006 → Sep 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11156610B2 | Methods for reducing interferences | Physics | 2 | Active |
| US7604935B2 | Soluble rubella E1 envelope protein variants | Emerging Cross-Sectional Technologies | 2 | Active |
| US8835637B2 | Iridium-based complexes for ECL | Physics | 1 | Active |
| US8772486B2 | Iridium-based complexes for ECL | Physics | 1 | Active |
| US12411129B2 | Reduction of interferences in immunoassays | Physics | 0 | Active |
| US8551696B2 | Rubella E1 envelope protein variants and their use in detection of anti-rubella antibodies | Emerging Cross-Sectional Technologies | 0 | Active |
| US11327077B2 | Pretreatment method for rapid detection of HCV core antigen | Physics | 0 | Active |
| US10094828B2 | Antigen composition for detecting Chagas disease | Physics | 0 | Active |
| US11391733B2 | Particle-based immunoassay using a pegylated analyte-specific binding agent | Physics | 0 | Active |
| US11078241B2 | Multi-epitope fusion protein of an HCV antigen and uses thereof | Physics | 0 | Active |
| US12399176B2 | Methods for reducing interferences | Physics | 0 | Active |
| US10228370B2 | Recombinant Trypanosoma cruzi JL7 antigen variants and their use for detecting Chagas disease | Emerging Cross-Sectional Technologies | 0 | Active |
| US11320423B2 | Method for reduction of interferences in immunoassays | Physics | 0 | Active |
| US11099180B2 | Immunoassay using at least two pegylated analyte-specific binding agents | Physics | 0 | Active |
| US11150247B2 | Method for serological detection of viral antigens | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.